Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Basal Cell”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableStudy completedNCT02131805
What this trial is testing

Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma

Who this might be right for
Cutaneous Basal CellSquamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT02059252
What this trial is testing

Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma
Smart Matrix Limited 5
Testing effectiveness (Phase 2)Study completedNCT00002963
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
Roswell Park Cancer Institute
Not applicableStudy completedNCT03836105
What this trial is testing

CemiplimAb Survivorship Epidemiology

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
Regeneron Pharmaceuticals 287
Not applicableStudy completedNCT02939027
What this trial is testing

Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
Instituto de Investigacion Sanitaria La Fe 40
Testing effectiveness (Phase 2)UnknownNCT04362722
What this trial is testing

Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients

Who this might be right for
Carcinoma, Basal CellCarcinoma, Cutaneous Squamous Cell
Philogen S.p.A. 40
Not applicableUnknownNCT06342297
What this trial is testing

Dermatoscopy Guided Resection for Skin Cancer

Who this might be right for
Basal Cell CarcinomaCutaneous Squamous Cell CarcinomaSurgical Margin
Region Örebro County 400
Not applicableLooking for participantsNCT05741073
What this trial is testing

Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC

Who this might be right for
Basal Cell CarcinomaCutaneous Squamous Cell Carcinoma
EuMelaReg gGmbH 1,300
Early research (Phase 1)UnknownNCT03775525
What this trial is testing

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Advanced CancerGastric CancerBreast Cancer+14 more
Genzada Pharmaceuticals USA, Inc. 127
Not applicableStudy completedNCT06279143
What this trial is testing

The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes

Who this might be right for
BCC - Basal Cell CarcinomaBCCSkin Diseases+2 more
Vejle Hospital 210
Testing effectiveness (Phase 2)Ended earlyNCT04916002
What this trial is testing

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+3 more
Regeneron Pharmaceuticals 77
Not applicableLooking for participantsNCT07215988
What this trial is testing

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Who this might be right for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center 70
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Not applicableStudy completedNCT00836342
What this trial is testing

Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer

Who this might be right for
Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma
Massachusetts General Hospital 81
Testing effectiveness (Phase 2)Study completedNCT00002975
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer

Who this might be right for
Non-melanomatous Skin CancerPrecancerous Condition
Roswell Park Cancer Institute 180
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Very early researchLooking for participantsNCT07286318
What this trial is testing

Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Who this might be right for
Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Actinic Keratosis (AK)+1 more
Marissa Lobl 20
Next Page